Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections
暂无分享,去创建一个
[1] B. Arulanandam,et al. Chlamydia and Its Many Ways of Escaping the Host Immune System , 2019, Journal of pathogens.
[2] W. Wong,et al. Chlamydiaceae: Diseases in Primary Hosts and Zoonosis , 2019, Microorganisms.
[3] Wei Bi,et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice , 2019, Scientific Reports.
[4] J. Correale,et al. The role of infections in multiple sclerosis , 2019, Multiple sclerosis.
[5] B. Arulanandam,et al. CPAF, HSP60 and MOMP antigens elicit pro-inflammatory cytokines production in the peripheral blood mononuclear cells from genital Chlamydia trachomatis-infected patients. , 2019, Immunobiology.
[6] M. Panzetta,et al. Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo , 2018, Front. Microbiol..
[7] J. Dagvadorj,et al. Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis. , 2018, Cell metabolism.
[8] D. Kell,et al. The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia , 2018, Front. Aging Neurosci..
[9] A. Yamamoto,et al. Intranasal rifampicin for Alzheimer's disease prevention , 2018, Alzheimer's & dementia.
[10] P. Shah,et al. Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis. , 2018, Journal of the American College of Cardiology.
[11] Alzheimer’s Association. 2018 Alzheimer's disease facts and figures , 2018, Alzheimer's & Dementia.
[12] F. Sharp,et al. Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review , 2018, Front. Aging Neurosci..
[13] Mark Ellisman,et al. Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis , 2018, Nature Communications.
[14] M. Wildung,et al. Genomewide Transcriptional Responses of Iron-Starved Chlamydia trachomatis Reveal Prioritization of Metabolic Precursor Synthesis over Protein Translation , 2017, mSystems.
[15] F. Radouani,et al. Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases. , 2017, Journal of infection and public health.
[16] D. Hahn,et al. Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides , 2017, Respiratory Research.
[17] S. Singh,et al. Modulation of Inflammation Induced by Recombinant MOMP of Chlamydia in Mouse Macrophages by IL-10 is Mediated by Skewing M1 to an M2 Polarizing Macrophage Phenotype , 2017, The Journal of Immunology.
[18] H. Ward,et al. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. , 2016, The Lancet. Infectious diseases.
[19] W. Klein,et al. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. , 2016, Brain : a journal of neurology.
[20] B. Arulanandam,et al. Temporal proteomic profiling of Chlamydia trachomatis–infected HeLa‐229 human cervical epithelial cells , 2016, Proteomics.
[21] R. Iramain,et al. Chlamydia pneumoniae, and mycoplasma pneumoniae: Are they related to severe asthma in childhood? , 2016, The Journal of asthma : official journal of the Association for the Care of Asthma.
[22] D. Hahn,et al. Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma? , 2016, The Lancet. Respiratory medicine.
[23] Anand K. Ramasubramanian,et al. Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci , 2016, Scientific Reports.
[24] A. Hudson,et al. Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research , 2016, Current Rheumatology Reports.
[25] A. Murthy,et al. CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice. , 2015, Pathogens and disease.
[26] J. Forrester,et al. High Chlamydia Burden Promotes Tumor Necrosis Factor–Dependent Reactive Arthritis in SKG Mice , 2015, Arthritis & rheumatology.
[27] A. Katsambas,et al. Reactive Arthritis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[28] D. Appelt,et al. Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae , 2014, Front. Aging Neurosci..
[29] H. Haller,et al. Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells , 2014, BMC Microbiology.
[30] Michael J. Emanuele,et al. Chlamydia trachomatis-induced alterations in the host cell proteome are required for intracellular growth. , 2014, Cell host & microbe.
[31] Kai Yin,et al. Foam cells in atherosclerosis. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[32] J. Esdaile,et al. Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis , 2013, The Journal of Rheumatology.
[33] S. Yale,et al. Azithromycin for Bronchial Asthma in Adults: An Effectiveness Trial , 2012, The Journal of the American Board of Family Medicine.
[34] D. Hahn,et al. Chlamydia pneumoniae-Specific IgE Is Prevalent in Asthma and Is Associated with Disease Severity , 2012, PloS one.
[35] N. Hanania,et al. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. , 2012, Respiratory medicine.
[36] K. A. Fields,et al. Disulfide Bonding within Components of the Chlamydia Type III Secretion Apparatus Correlates with Development , 2011, Journal of bacteriology.
[37] O. Cissé,et al. Permissivity of Vero cells, human pneumocytes and human endometrial cells to Waddlia chondrophila. , 2011, Microbes and infection.
[38] J. Gottenberg,et al. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. , 2011, Arthritis and rheumatism.
[39] J. Rupp,et al. Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo , 2010, Proceedings of the National Academy of Sciences.
[40] D. Appelt,et al. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain , 2010, BMC Neuroscience.
[41] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[42] J. Carter,et al. The pathogenic role of Chlamydia in spondyloarthritis , 2010, Current opinion in rheumatology.
[43] J. Carter,et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. , 2010, Arthritis and rheumatism.
[44] J. Carter. Treating reactive arthritis: insights for the clinician , 2010, Therapeutic advances in musculoskeletal disease.
[45] G. Zummo,et al. Chlamydia trachomatis Infection and Anti-Hsp60 Immunity: The Two Sides of the Coin , 2009, PLoS pathogens.
[46] S. Hatachi,et al. Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases , 2009, Lupus.
[47] D. Vergani,et al. Bacteria and Primary Biliary Cirrhosis , 2009, Clinical reviews in allergy & immunology.
[48] M. McGrath,et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS) , 2009, Journal of Neuroimmunology.
[49] G. Schiavoni,et al. Chlamydia Pneumoniae and Atherosclerosis: Current State and Future Prospectives , 2009, International journal of immunopathology and pharmacology.
[50] Nicholas J Alp,et al. Role of Chlamydia pneumoniae in atherosclerosis. , 2008, Clinical science.
[51] H. Gérard,et al. Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells. , 2008, Microbial pathogenesis.
[52] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[53] K. Hybiske,et al. Mechanisms of host cell exit by the intracellular bacterium Chlamydia , 2007, Proceedings of the National Academy of Sciences.
[54] H. Steinbusch,et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection , 2007, Acta Neuropathologica.
[55] H. Steinbusch,et al. Chlamydia pneumoniae infection of brain cells: An in vitro study , 2007, Neurobiology of Aging.
[56] J. Treib,et al. Long-term Antibiotic Treatment with Roxithromycin in Patients with Multiple Sclerosis , 2006, Infection.
[57] H. Gérard,et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. , 2006, FEMS immunology and medical microbiology.
[58] C. Stratton,et al. Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae. , 2006, Trends in microbiology.
[59] G. Cutter,et al. Infectious causes of multiple sclerosis , 2006, The Lancet Neurology.
[60] P. Bagos,et al. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis , 2006, Multiple sclerosis.
[61] M. Hernán,et al. Antibiotic use and risk of multiple sclerosis. , 2006, American journal of epidemiology.
[62] F. Blasi,et al. Chlamydia pneumoniae and Mycoplasma pneumoniae. , 2005, Seminars in respiratory and critical care medicine.
[63] S. Johnston,et al. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? , 2005, American journal of respiratory and critical care medicine.
[64] D. Virok,et al. Chlamydial IFN-γ immune evasion is linked to host infection tropism , 2005 .
[65] R. Zhong,et al. Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. , 2005, World journal of gastroenterology.
[66] J. Ager,et al. The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. , 2005, Microbial pathogenesis.
[67] P. Leanderson,et al. Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase- dependent production of reactive oxygen species in platelets , 2005, Thrombosis and Haemostasis.
[68] P. Salvà,et al. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. , 2005, American journal of respiratory and critical care medicine.
[69] R. Brunham,et al. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.
[70] E. Märker-Hermann,et al. Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor α and interferon γ , 2004 .
[71] J. Carter,et al. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. , 2004, The Journal of rheumatology.
[72] H. Zeidler,et al. Chlamydia-induced arthritis , 2004, Current opinion in rheumatology.
[73] D. Appelt,et al. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice , 2004, Neurobiology of Aging.
[74] W. Solbach,et al. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature For editorial comments see page 499. , 2004, European Respiratory Journal.
[75] Michael Borrie,et al. A Randomized, Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer's Disease , 2004, Journal of the American Geriatrics Society.
[76] S. Ouellette,et al. Chlamydia pneumoniae and atherosclerosis , 2004, Cellular microbiology.
[77] D. Virok,et al. Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[78] HannaKälvegren,et al. Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation , 2003 .
[79] T. Bengtsson,et al. Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation: A Causal Role in Cardiovascular Disease? , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[80] R. Coppel,et al. Is there a Relation between Chlamydia Infection and Primary Biliary Cirrhosis? , 2003, Clinical & developmental immunology.
[81] D. Appelt,et al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells , 2003, Journal of neuroscience research.
[82] Lisa Chasan-Taber,et al. Infection with Chlamydia pneumoniae and Risk of Multiple Sclerosis , 2003, Epidemiology.
[83] D. Appelt,et al. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. , 2002, FEMS microbiology letters.
[84] G. Wilcock,et al. Failure to correlate C. pneumoniae with late onset Alzheimer's disease. , 2002, Neurology.
[85] K. Lindor,et al. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? , 2002, Journal of hepatology.
[86] L. V. von Hertzen. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae , 2002, European Respiratory Journal.
[87] H. Gérard,et al. Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection , 2001, Molecular microbiology.
[88] H. Gérard,et al. A Chlamydia pneumoniae-Specific Peptide Induces Experimental Autoimmune Encephalomyelitis in Rats1 , 2001, The Journal of Immunology.
[89] T. Derfuss,et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. , 2001, Brain : a journal of neurology.
[90] Yoshimasa Yamamoto,et al. PCR-Based Method for Isolation and Detection of Chlamydia pneumoniae DNA in Cerebrospinal Fluids , 2001, Clinical Diagnostic Laboratory Immunology.
[91] F. Hanefeld,et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis , 2001, Annals of neurology.
[92] D. Taylor-Robinson,et al. How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted? , 2001, Annals of the rheumatic diseases.
[93] M. Hammerschlag,et al. Is Chlamydia pneumoniae Present in Brain Lesions of Patients with Multiple Sclerosis? , 2000, Journal of Clinical Microbiology.
[94] H. Gérard,et al. Chlamydia pneumoniae present in the human synovium are viable and metabolically active. , 2000, Microbial pathogenesis.
[95] R. Ring,et al. Failure To Detect Chlamydia pneumoniaein the Late-Onset Alzheimer's Brain , 2000, Journal of Clinical Microbiology.
[96] A. Grau,et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis , 2000, Annals of neurology.
[97] W. Solbach,et al. Failure To Detect Chlamydia pneumoniaein Brain Sections of Alzheimer's Disease Patients , 2000, Journal of Clinical Microbiology.
[98] H. Gérard,et al. Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. , 1999, Arthritis and rheumatism.
[99] C. Stratton,et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis , 1999, Annals of neurology.
[100] J. Ramirez,et al. Infection of Human Endothelial Cells with Chlamydia pneumoniae Stimulates Transendothelial Migration of Neutrophils and Monocytes , 1999, Infection and Immunity.
[101] J. Neuberger,et al. PBC and AMA—what is the connection? , 1999, Hepatology.
[102] D. Appelt,et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.
[103] L. Campbell,et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. , 1998, The Journal of infectious diseases.
[104] J. Ayres,et al. Chlamydia pneumoniae and asthma , 1998, Thorax.
[105] C. Stratton,et al. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS , 1998, Neurology.
[106] S. Johnston,et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. , 1998, The European respiratory journal.
[107] O. Moling,et al. Chlamydia pneumoniae--reactive arthritis and persistent infection. , 1996, British journal of rheumatology.
[108] E. O’Brien,et al. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae , 1995, Journal of clinical microbiology.
[109] Y. Shemer-Avni,et al. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. , 1995, The Journal of infectious diseases.
[110] H. Mori,et al. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. , 1994, Biochemical and biophysical research communications.
[111] W. Beatty,et al. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence , 1994, Infection and immunity.
[112] P. Wu,et al. Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis. , 1994, Annals of the rheumatic diseases.
[113] A. Hassell,et al. Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones. , 1993, Immunology.
[114] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[115] M. Kaplan,et al. Primary Biliary Cirrhosis , 1987, The New England journal of medicine.
[116] J. Schachter,et al. Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis , 1984, Infection and immunity.
[117] J. Scott,et al. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. , 1980, Annals of the rheumatic diseases.
[118] N. Ilbäck,et al. Cholesterol uptake in the mouse aorta increases during Chlamydia pneumoniae infection , 2017, Pathogens and disease.
[119] R. Inman,et al. Chlamydia-induced ReA: immune imbalances and persistent pathogens , 2012, Nature Reviews Rheumatology.
[120] D. Virok,et al. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[121] D. Scott,et al. Arthritis associated with venereal disease in nineteenth century London , 2005, Clinical Rheumatology.
[122] Journal of Neuroinflammation BioMed Central Review Involvement of β-chemokines in the development of inflammatory demyelination , 2005 .
[123] D. Virok,et al. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[124] H. L. Von,et al. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. , 2002, The European respiratory journal.
[125] J. Pearce,et al. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. , 1996, The Journal of rheumatology.
[126] U. Yli-Kerttula,et al. Chlamydial isolations and serology in Reiter's syndrome. , 1981, Scandinavian journal of rheumatology.